Cancer cell inhibitory drug and cancer stem-cell detection probe
US-2015274715-A1 · Oct 1, 2015 · US
US9764046B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9764046-B2 |
| Application number | US-201514601480-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 21, 2015 |
| Priority date | Dec 25, 2008 |
| Publication date | Sep 19, 2017 |
| Grant date | Sep 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides a labeling composition for an intraocular tissue of a living individual, which specifically labels the intraocular tissue without need of an invasive operation such as exposure of an ocular tissue or injection of a staining agent into the ocular tissue or a nerve tissue linking to the ocular tissue, a method of noninvasively labeling an intraocular tissue of a living individual, and a screening method using the labeling composition for the intraocular tissues. The composition contains a compound capable of labeling at least a photoreceptor cell layer of a retina, wherein the compound is a staining compound having a particular structure as a partial structure thereof.
Opening claim text (preview).
The invention claimed is: 1. An imaging method for an intraocular tissue comprising: bringing a labeling composition for the intraocular tissue or a staining agent for the intraocular tissue, which comprises the labeling composition for the intraocular tissue, into contact with the ocular tissue; irradiating the intraocular tissue with excitation light to observe fluorescence; and acquiring a fluorescent image, wherein the labeling composition comprises a fluorescent compound capable of labeling at least a photoreceptor cell layer of a retina, and wherein the fluorescent compound is selected from the group consisting of compounds (1)-(9), (11)-(13), (32), (33), (87), (90)-(95), and (109)-(112): 2. An evaluating method for a condition of a retina comprising: imaging an intraocular tissue by the imaging method according to claim 1 ; and evaluating the condition of the retina using the obtained fluorescent image.
Sulfur atoms · CPC title
with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 · CPC title
in which the condensed system contains three hetero rings · CPC title
of vertebrates · CPC title
Spiro-condensed ring systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.